FGFR2 fusion partners reported to date in GC include TACC2, INPP5F, WDR11 and BTBD16, and in most cases, these tumours harboured concurrent FGFR2 gene amplification [28,34,35]. This evidence concerns the gene FGFR2 and neoplasm.